{"context":{"query":">>mesh>>pharmgkb_clinical","source_dataset":"mesh","target_dataset":"pharmgkb_clinical"},"stats":{"queried":1,"total":25,"mapped":1},"pagination":{"has_next":false},"schema":"id|variant|gene|type|level_of_evidence|chemicals|phenotypes","mappings":[{"input":"D015212","source":"D015212|Inflammatory Bowel Diseases","targets":["HLA-DQA1*02:01_HLA-DQA1_1|HLA-DQA1*02:01|HLA-DQA1|Toxicity|3|azathioprine;mercaptopurine|Drug Toxicity;Inflammatory Bowel Diseases;Pancreatitis","HLA-DQA1*05_HLA-DQA1_1|HLA-DQA1*05|HLA-DQA1|Efficacy|3|Tumor necrosis factor alpha (TNF-alpha) inhibitors|Inflammatory Bowel Diseases","HLA-DRB1*07:01_HLA-DRB1_1|HLA-DRB1*07:01|HLA-DRB1|Toxicity|3|azathioprine;mercaptopurine|Drug Toxicity;Inflammatory Bowel Diseases;Pancreatitis","RS10499563_IL6_1|rs10499563|IL6|Efficacy|3|Tumor necrosis factor alpha (TNF-alpha) inhibitors|Inflammatory Bowel Diseases;Ulcerative Colitis","RS1127354_DDRGK1_ITPA_1|rs1127354|DDRGK1,ITPA|Efficacy|3|azathioprine|Inflammatory Bowel Diseases","RS116855232_NUDT15_2|rs116855232|NUDT15|Toxicity|1A|azathioprine|Inflammatory Bowel Diseases;Myelosuppression","RS11938228_TLR2_1|rs11938228|TLR2|Efficacy|3|Tumor necrosis factor alpha (TNF-alpha) inhibitors|Inflammatory Bowel Diseases;Psoriasis","RS11969064_1|rs11969064||Toxicity|3|azathioprine;mercaptopurine;thioguanine|Inflammatory Bowel Diseases;Myelosuppression","RS1554973_CNPY4_1|rs1554973|CNPY4|Efficacy|3|Tumor necrosis factor alpha (TNF-alpha) inhibitors|Inflammatory Bowel Diseases","RS2097432_1|rs2097432||Efficacy|3|infliximab|Inflammatory Bowel Diseases","RS2275913_IL17A_1|rs2275913|IL17A|Efficacy|3|Tumor necrosis factor alpha (TNF-alpha) inhibitors|Inflammatory Bowel Diseases;Ulcerative Colitis","RS2430561_IFNG_1|rs2430561|IFNG|Efficacy|3|Tumor necrosis factor alpha (TNF-alpha) inhibitors|Crohn Disease;Inflammatory Bowel Diseases","RS2647087_1|rs2647087||Toxicity|3|azathioprine;mercaptopurine|Drug Toxicity;Inflammatory Bowel Diseases;Pancreatitis","RS352139_TLR9_1|rs352139|TLR9|Efficacy|3|Tumor necrosis factor alpha (TNF-alpha) inhibitors|Crohn Disease;Inflammatory Bowel Diseases","RS3765534_ABCC4_1|rs3765534|ABCC4|Toxicity|3|azathioprine;mercaptopurine|Inflammatory Bowel Diseases","RS3804099_TLR2_1|rs3804099|TLR2|Efficacy|3|Tumor necrosis factor alpha (TNF-alpha) inhibitors|Inflammatory Bowel Diseases","RS4149570_TNFRSF1A_1|rs4149570|TNFRSF1A|Efficacy|3|Tumor necrosis factor alpha (TNF-alpha) inhibitors|Crohn Disease;Inflammatory Bowel Diseases","RS4848306_IL1B_1|rs4848306|IL1B|Efficacy|3|Tumor necrosis factor alpha (TNF-alpha) inhibitors|Inflammatory Bowel Diseases;Ulcerative Colitis","RS5030728_TLR4_1|rs5030728|TLR4|Efficacy|3|Tumor necrosis factor alpha (TNF-alpha) inhibitors|Inflammatory Bowel Diseases","RS510432_ATG5_1|rs510432|ATG5|Efficacy|3|adalimumab|Inflammatory Bowel Diseases","RS55754655_AOX1_1|rs55754655|AOX1|Efficacy|3|azathioprine|Inflammatory Bowel Diseases","RS6927172_TNFAIP3_1|rs6927172|TNFAIP3|Efficacy|3|Tumor necrosis factor alpha (TNF-alpha) inhibitors|Inflammatory Bowel Diseases;Ulcerative Colitis","RS7270101_ITPA_3|rs7270101|ITPA|Toxicity|4|azathioprine|Inflammatory Bowel Diseases","RS746071566_NUDT15_3|rs746071566|NUDT15|Toxicity|3|azathioprine;mercaptopurine;thioguanine|Inflammatory Bowel Diseases;Myelosuppression","RS9373839_ATG5_1|rs9373839|ATG5|Efficacy|3|adalimumab|Inflammatory Bowel Diseases"]}]}